Professional Documents
Culture Documents
Human Intestinal Absorption positive(0.9627) Positive 0.9928 Positive 0.987 Positive 0.9923
Caco-2 positive(0.5622) Negative 0.5643 Positive 0.8866 Positive0.8769
Blood Brain Barrier positive(0.9803) Positive 0.9973 Positive 0.9462 Positive0.8950
Human oral bioavailability positive(0.6571) Positive 0.5571 Positive 0.7571 Positive0.7714
Subcellular localzation Mitochondria Mitochondria Mitochondria Mitochondria
P-glycoprotein inhibitior Negative(0.9026) Negative 0.9497 Negative 0.5346 Negative 0.6153
P-glycoprotein substrate Negative(0.9732) Negative 0.8831 Negative0.8501 Negative 0.8264
CYP3A4 substrate Negative(0.6163)NeNegative 0.5486 Positive 0.5822 Positive 0.5868
CYP2C9 substrate Negative(1.0000) Ngative 0.8027 Negative 0.7977 Negative0.8100
Negative 0.7680
Negative 0.6486
Positive 0.7219
Positive 0.8490
Negative 0.6027
Positive 0.9463
Negative 0.9078
Positive 0.5600
Positive 0.8250
III 0.5767
Name ChEMBL ID Canonical SMILES
Sampangine CHEMBL435201 C1=CC=C2C(=C1)C3=NC=CC4=C3C(=NC=C4)C2=O
Formula MW Rotatable bonds H-bond acceptors H-bond donors TPSA
C15H8N2O 232.24 0 3 0 42.85 Ų
Consensus Log P CYP1A2 inhibitor CYP2C19 inhibitor CYP2C9 inhibitor CYP2D6 inhibitor
2.35 Yes Yes No Yes
CYP3A4 inhibitor Lipinski #violations Ghose #violations Veber #violations
Yes Yes; 0 violation Yes Yes
Egan #violations Muegge #violations
Yes Yes